Application 040263
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | INJECTABLE;INJECTION | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | No | Yes |
| 002 | METHOTREXATE SODIUM | METHOTREXATE SODIUM | INJECTABLE;INJECTION | EQ 250MG BASE/10ML (EQ 25MG BASE/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 63323-123 | Methotrexate | METHOTREXATE SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-123 | Methotrexate | METHOTREXATE SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-123 | Methotrexate | METHOTREXATE SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 17759 | ORIG | 2004-06-09 |
| 22109 | ORIG | 2003-07-31 |
| 29905 | ORIG | 1999-02-26 |